Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 04, 2025 21:12 ET | Source: Helius Medical Technologies, Inc. NEWTOWN,…
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit United for Progress: A New Chapter in Sarcoidosis
CHICAGO, June 04, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
Miles Education and St. James School of Medicine partner to enable Indian NEET Qualifiers to become Licensed U.S. Doctors
BANGALORE, India, June 4, 2025 /PRNewswire/ -- Miles Education, a global ed-tech leader…
World’s Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium,…
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris:…
Roches Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)
Simplified storage and administration of new tablet formulation may provide greater freedom…